---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-23-004464"
form_type: "8-K"
ticker: "ZEOX"
cik: "0001557376"
company_name: "Zeo ScientifiX, Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T14:52:35.473967+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Organicell appoints Howard Golub as EVP/CSO; 30+ years in clinical therapeutics

## Summary
- Howard L. Golub, MD, PhD appointed EVP and Chief Science Officer effective June 29, 2023.
- Dr. Golub brings over 30 years of clinical research experience, including VP R&D at Walgreens Boots Alliance and founding CareStat LLC.
- He will lead Organicell's R&D for innovative regenerative biologic therapies.
- CEO Harry Leider stated the appointment strengthens the company's research leadership.

## SEC filing metadata
- accession: 0001829126-23-004464
- form_type: 8-K
- ticker: ZEOX
- cik: 0001557376
- company_name: Zeo ScientifiX, Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557376/000182912623004464/0001829126-23-004464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557376/000182912623004464/organicellrege_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-23-004464
- JSON: https://secwatch.observer/filing/0001829126-23-004464.json
- Plain text: https://secwatch.observer/filing/0001829126-23-004464.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.